BGI Shenzhen Co., Ltd. – Trademark Portfolio
Entity Type: 99
BGI Shenzhen Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BGI · NUTRI. The owner is based in Shenzhen, Guangdong.
8F, Building 11, Beishan Industrial Zone
#146 Beishan Rd, Yantian District,
Shenzhen, Guangdong 518083 , CN
Showing of trademarks Trademarks
Trademark Classifications
BGI Shenzhen Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does BGI Shenzhen Co., Ltd. have?
BGI Shenzhen Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does BGI Shenzhen Co., Ltd. file in?
BGI Shenzhen Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.
What are BGI Shenzhen Co., Ltd.'s most well-known trademarks?
BGI Shenzhen Co., Ltd.'s registered trademark portfolio includes well-known marks such as BGI · NUTRI. These are among 1 currently registered trademark in the portfolio.
What is BGI Shenzhen Co., Ltd.'s trademark registration success rate?
BGI Shenzhen Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.